Monica Case Vice President of the American Association of Medical Assistants
CHICAGO, May 3, 2023 (Newswire.com)
–
The American Association of Me…
The post The AAMA Installs Monica Case, CMA (AAMA), as the 2022-2023 AAMA Vice President first appeared on Enrose Magazine.
2023 Magic Quadrant Apprentice ranks as a Visionary in the 2023 Magic Quadrant for manufacturing Execution Systems
JERSEY CITY, N.J., May 3, 2023 (Newswire.com)
…
The post Apprentice.io Placed in 2023 Magic Quadrant for Manufacturing Execution Systems first appeared on Enrose Magazine.
PolarSeal®, a leading medical device contract manufacturer and flexible material converter, is pleased to announce the launch of its new Training Academy – “Operational Excellence” – a training program designed to enha…
The post PolarSeal Invests in Staff Training Academy first appeared on Enrose Magazine.
TEL AVIV, Israel, May 2, 2023 (Newswire.com)
–
Imagene, an emerging leader in the field of AI-based precision oncology, is proud to announce its win of the Frost & Sullivan 2023 Europe Technology Innovation Leadership Award in AI-based molecular testing for cancer diagnosis.
Frost & Sullivan Best Practices awards recognize companies for demonstrating outstanding achievement and superior performance in leadership and technological innovation. Imagene AI has been acknowledged for its groundbreaking technology and commitment to innovation and creativity in supporting physicians and patients.
Ashish Kaul, industry analyst at Frost & Sullivan, said, “Imagene’s AI-based molecular testing technology scales to streamline cancer care processes and needs. It accelerates cancer diagnosis via accurate, image-based, immediate biomarker profiling, overcoming existing barriers and revolutionizing the market. Frost & Sullivan anticipates rapid, widespread technology adoption.”
Imagene AI’s technology can detect a wide range of cancer biomarkers in real-time, generating immediate genomic insights from digitized biopsy images alone. By reducing the time-to-results of molecular testing from several weeks to minutes, Imagene’s AI-based solution transforms cancer diagnosis and advances precision medicine.
“We are honored to receive this prestigious award from Frost & Sullivan, which validates our dedication to delivering world-class AI-based molecular testing solutions for cancer diagnosis,” said Dean Bitan, Co-founder and CEO of Imagene. “Our mission is to provide healthcare professionals with immediate and accurate biomarker profiling, empowering them with crucial information that enables optimal navigation in the complex cancer diagnosis process. This recognition affirms our commitment to innovation and to helping cancer patients in getting the most optimal treatment medicine can offer.”
Frost & Sullivan recognizes the high value and accuracy levels of Imagene’s AI-based molecular diagnosis solution and its strategic partnerships with leading medical centers and pharmaceutical companies worldwide. Imagene’s technology also supports pharmaceutical companies’ drug research and development activities, enabling optimal patient stratification for clinical trial optimization.
With its strong overall performance and dedication for bringing value to physicians and patients, Imagene AI is poised to set new market trends and address unmet needs in cancer care. The Frost & Sullivan 2023 Europe Technology Innovation Leadership Award recognizes Imagene’s ongoing excellence and pioneering leadership role in the AI-based molecular testing for cancer diagnosis market.
About Imagene
Imagene is an emerging leader in the field of AI-based precision oncology, leveraging AI to profile, in real-time, a broad range of cancer biomarkers from a digitized biopsy image alone. Imagene’s AI-based molecular diagnostic solutions streamline cancer care processes and accelerate cancer diagnosis through precise, image-based, immediate biomarkers profiling.
Imagene is an award-winning diverse BioMed startup with an experienced, passionate and bright team. Our success derives from our cutting-edge technology and multidisciplinary team of data scientists, biologists, software engineers, and medical experts. The company collaborates with top-tier medical centers and pharmaceutical companies worldwide.
For more information, visit www.imagene.ai.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
Contact Information:
Avital Rabani
Head of Marketing
Original Source:
Imagene Wins Frost & Sullivan’s Technology Innovation Leadership Award for Its Revolutionary AI-Based Molecular Testing for Cancer Diagnosis
The post Imagene Wins Frost & Sullivan’s Technology Innovation Leadership Award for Its Revolutionary AI-Based Molecular Testing for Cancer Diagnosis first appeared on Enrose Magazine.
From the 13th to the 15th of June, Starrag will be exhibiting at the Orthopedic Manufacturing & Technology Exposition and Conference (OMTEC) in Chicago. On Booth 447, the world’s leading machine tool manufacturer will demonstrate its expertise in this arena by showcasing the Starrag Bumotec 191neo.
HEBRON, Ky., May 2, 2023 (Newswire.com)
–
With 12 different variants built upon a single platform, the new Starrag Bumotec 191neo is a multi-axis mill/turn center that introduces a world of flexible and highly productive machining solutions. At the OMTEC exhibition, the Starrag Bumotec 191neo will be demonstrating just how flexible, productive and capable a machine it is with the one-hit production of a bone plate. Manufactured in volume throughout the medical industry, bone plates are particularly challenging to machine – but not for the Starrag Bumotec 191neo.
For manufacturers in the medical profession, the difficulty when producing bone plates is the ability to machine and subsequently finish the plates on all six sides in a single operation whilst striving for optimized cycle times and lights-out 24/7 production. On the booth at OMTEC, the machine will feed a 1.2-inch (30 mm) diameter titanium bar into the work envelope and deploy 20 different cutting tools to 26 operations to finish machine the bone plate in under 20 minutes. The challenge, as a medical device manufacturer would appreciate, is the complex machining of a long part between two stations whilst retaining perfect synchronization. Not only does the new Starrag Bumotec 191neo productively achieve this by machining the bone plates from bar stock in its robust work envelope, but it eradicates any requirement for secondary operations.
The epitome of high-end machining, the Starrag Bumotec 191neo will machine the bone plate at OMTEC in a single operation with impeccable surface finishes, leaving a part that is burr-free and free of tabs – and then delicately placing the parts into a collection receptacle for complete unmanned production. With such stringent regulations in the medical industry, machining bone plates with absolute confidence and quality conformity whilst delivering a completely automated production cell is exactly why manufacturers need to see the Starrag Bumotec 191neo at OMTEC.
The impressive new Starrag Bumotec 191neo is available in four versions, the ‘P’ with vice, ‘PRM’ with a multi-purpose pickup vice, the ‘R’ with a back-working spindle and the ‘RP’ with a combined vice and back-working spindle. Providing a choice of bar capacities of 1.7, 2, 2.6 inch (42, 50 or 65 mm), manufacturers can choose one of 12 machine configurations that are all based upon the same rigid and extremely robust.
Maintaining unparalleled thermal and performance stability during production, the Starrag Bumotec 191neo offers a formidable level of productivity. Compared to previous models, the new machine has a new tool change system that reduces changeovers by more than 15%. The machine also has a new milling spindle with increased torque and a back-working movement that is controlled by an electric motor. This combination provides the perfect blend of high-speed cutting with the power and rigidity for increased material removal rates whilst enhancing positional control.
The high-performance Starrag spindle is fed cutting tools from its 90-position tool magazine that now has an integrated tool breakage probe to support lights-out production runs. Further advancing the automation credentials of the new machine is the option of a traditional Bumotec palletizer or a robotic, modular or custom-made automated cell that delivers true ’24/7′ production, which is only interrupted by preventive maintenance when required. If you want to optimize your productivity with a completely flexible solution that can undertake the machining of a diverse range of component types, please come and visit Booth 447 at the OMTEC show in June.
Contact Information:
Elena Schmidt-Schmiedebach
Marketing Manager North America, Canada and Mexico
+18593802356
Original Source:
Starrag’s New Bumotec Machine Picks Through the Bones of Complex Manufacturing
The post Starrag’s New Bumotec Machine Picks Through the Bones of Complex Manufacturing first appeared on Enrose Magazine.
TBS Dental introduces elvatome 2.0, a revolutionary dental instrument for precise and effortless tooth extractions.
elvatome 2.0 Straight elvatom…
The post TBS Dental Launches Elvatome 2.0, Redefining Tooth Extractions With Advanced Engineering and Precision first appeared on Enrose Magazine.
Ark Animal Hospital Logo
CHALFONT, Pa., May 1, 2023 (Newswire.com)
–
Ark Animal Hospital is proud to announce its 30th-anniversary celebration on May 6…
The post Ark Animal Hospital Celebrates 30th Anniversary With RSVP Celebration first appeared on Enrose Magazine.
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Rett Syndrome
ORLANDO, Fla., …
The post The Assistance Fund Opens New Program for Rett Syndrome first appeared on Enrose Magazine.
PEPPER PIKE, Ohio, May 1, 2023 (Newswire.com)
–
Ursuline College announces the addition of a nurse anesthesia specialty to its Doctor of Nursing Practic…
The post Ursuline College Adds New Nurse Anesthesia Program Through Innovative Corporate Collaboration first appeared on Enrose Magazine.
Studies show hamstring and UCL injuries are most common in opening weeks, and sustained acoustic medicine is effective treatment for those soft-tissue injuries.
TRUMBULL, Conn., April 28, 2023 (Newswire.com)
–
Baseball is back, which means balls and strikes, hits and homers – and hamstring injuries. Studies show baseball’s most common injury, hamstring tendon tears, is more prevalent in the season’s first weeks, as is a common elbow injury. And this spring, both could become more frequent as rule changes reduce players’ recovery time between pitches and plays. One way to mitigate the risks of these injuries is ZetrOz Systems’ sustained acoustic medicine sam® device, which effectively treats soft-tissue injuries and can help players stay on the diamond.
The ZetrOZ sam® X1 and 2.0 devices are the only FDA-cleared wearable ultrasound units approved for daily home use. The low-intensity, long-duration ultrasound technology expedites the injury healing process without invasive surgery or potentially addictive painkillers and is clinically proven by more than 40 studies to reduce pain and improve function.
“We work with medical professionals nationwide, from orthopedic surgeons to athletic trainers, and they have used sam® to successfully treat thousands of professional and amateur athletes,” said Dr. George Lewis, founder and CEO of ZetrOZ Systems. “We know those injuries are more likely to occur at the start of a season, especially in baseball, and our technology can help mitigate risk and improve healing of those injuries.”
Several studies document the prevalence of injuries early in a season. A 2019 study in The Orthopaedic Journal of Sports Medicine used six years of Major League Baseball’s own injury tracking database to examine trends in hamstring injuries, which it found was the most common injury in baseball.
“In various professional sports leagues (NFL, NBA, MLB), hamstring strains have been found to occur earlier in the season. Our study found similar results, with the highest number of hamstring sprains in April and May,” the authors reported. “These factors may have an association with poor conditioning at the start of the season.”
About 40 percent of hamstring injuries occur in April and May, the analysis found. The rate of hamstring strains in Major League Baseball increased from one injury every 39 games in 2011 to one in every 30 games in 2016, with a similar trend in minor league baseball.
The pattern was the same in injuries to the elbow’s ulnar collateral ligament (UCL), according to a 2021 report from the Journal of Shoulder and Elbow Surgery, with April and May as peak months for UCL injuries. They also found that injuries within the first 90 days of the season were more severe, more commonly requiring surgery to repair them.
“Throwing athletes may have increased risk for an elbow injury at the start of the season because they have not attained midseason levels of muscle strength and endurance,” the authors wrote. They also found that pitchers’ shoulders had less range of motion early in the season, likely making them more vulnerable to injury.
Some observers fear injuries will be more common this year, with Major League Baseball now using a pitch clock that requires pitchers to throw to the batter within 15 seconds, or 20 seconds with a runner on base. That means pitchers have less recovery time between pitches, and batters have less recovery from swings or from running out foul balls.
A 2016 study in the Journal of Sports Science modeled the effects of the shorter rest period on pitching. The authors found that players would have more fatigue in the forearm muscles that stabilize the elbow, “increasing strain on the ulnar collateral ligament (UCL) and possibly increasing injury risk.”
Treatment with ZetrOZ’s sam® technology effectively treats injuries to tendons of the leg, elbow and other areas of the body. Among many studies demonstrating the system’s efficacy, a 2015 level 4 clinical study by sports medicine experts at The Ohio State University and Duke University found sustained acoustic medicine delivered via ZetrOZ’s sam® reduced pain and improved strength in patients’ medial/lateral elbow tendons and Achilles’ tendons.
Sustained acoustic medicine works by increasing blood vessel diameters to improve blood flow. That increases oxygenated hemoglobin at the site of the therapy and removes cytokine enzymes and cellular waste, with a result of more rapid healing and reduced pain.
“We know from our relationships with trainers across professional and college sports, as well physicians treating recreational athletes, that sam® heals athletes’ soft-tissue injuries more rapidly and helps players stay on the field or return to it more quickly,” Lewis said. “As baseball season begins and teams adapt to this new environment, sam® is available to help players stay healthy and on the diamond doing what they love.”
ZetrOZ Systems’ sam® technology was developed in part with funding from the National Institute of Health, National Science Foundation, Department of Defense and NASA. ZetrOZ Systems products are designed and manufactured in the United States and are protected by 46 U.S. patents.
To learn more, visit www.samrecover.com.
About ZetrOZ Systems
ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of +46 patents and is the exclusive manufacturer and developer of the sam® product line, which is designed for the treatment of acute and chronic musculoskeletal conditions.
Contact Information:
Maria Penaloza
Original Source:
As Baseball Season Begins With New Rules, ZetrOZ Systems’ sam Technology is Critical for Mitigating Injury Risk
The post As Baseball Season Begins With New Rules, ZetrOZ Systems’ sam Technology is Critical for Mitigating Injury Risk first appeared on Enrose Magazine.
Copyright © 2024 | WordPress Theme by MH Themes